Evidence map›Paper›PMID 28224364›Full record

ArticleAnnals of surgical oncology2017

The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma.

Maris S Jones, Peter C Jones, Stacey L Stern, David Elashoff, Dave S B Hoon, John Thompson, Nicola Mozzillo, Omgo E Nieweg, Dirk Noyes, Harald J Hoekstra and 16 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Annals of surgical oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Impact of particulate matter exposure on melanoma risk: A multicentre case-control study.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
    Observational
  4. Life Factors and Melanoma: From the Macroscopic State to the Molecular Mechanism.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Daily Lifestyle and Cutaneous Malignancies.International journal of molecular sciences · 2021
    Review
  12. α9-Containing Nicotinic Receptors in Cancer.Frontiers in cellular neuroscience · 2021
    Review
  13. Fine Particulate Matter Air Pollution and Mortality among Pediatric, Adolescent, and Young Adult Cancer Patients.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 19 institutions in 6 countries.

Maris S JonesDivision of Surgical Oncology, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, USA.
Peter C JonesDivision of Surgical Oncology, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, USA.
Stacey L SternDepartment of Biostatistics, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, USA.
David ElashoffUCLA Department of Biostatistics, Los Angeles, CA, USA.
Dave S B HoonDepartment of Molecular Oncology, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, USA.
John ThompsonMelanoma Institute Australia, Sydney, NSW, Australia.
Nicola MozzilloIstituto Nazionale dei Tumori Napoli, Napoli, Italy.
Omgo E NiewegMelanoma Institute Australia, Sydney, NSW, Australia.
Dirk NoyesIHC Cancer Services, Intermountain Medical Center, Salt Lake City, UT, USA.
Harald J HoekstraUniversitair Medisch Centrum Groningen, Groningen, The Netherlands.
Jonathan S ZagerH. Lee Moffitt Cancer Center, Tampa, USA.
Daniel F RosesNYU Langone Medical Center, New York, USA.
Alessandro TestoriIstituto Europeo di Oncologia, Milano, Italy.
Brendon J CoventryRoyal Adelaide Hospital Discipline of Surgery, Royal Adelaide HospitalUniversity of Adelaide, Adelaide, SA, Australia.
Mark B SmithersPrincess Alexandra Hospital, Woolloongabba, Queensland, Australia.
Robert AndtbackaHuntsman Cancer Institute, Salt Lake City, USA.
Doreen AgneseOhio State University, Columbus, USA.
Erwin SchultzNuremberg General Hospital - Paracelsus Medical University, Nuremberg, Germany.
Eddy C HsuehSaint Louis University, St. Louis, USA.
Mark KelleyVanderbilt University, Nashville, USA.
Schlomo SchneebaumTel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Lisa JacobsJohns Hopkins Medical Institute, Baltimore, USA.
Tawnya BowlesIHC Cancer Services, Intermountain Medical Center, Salt Lake City, UT, USA.
Mohammed Kashani-SabetCalifornia Pacific Medical Center, San Francisco, USA.
Douglas JohnsonVanderbilt University, Nashville, USA.
Mark B FariesDepartment of Melanoma Research, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, USA. mark.faries@jwci.org.
Saint John's Health Center · USIntermountain Medical Center · USMelanoma Institute Australia · AUMolecular Oncology (United States) · USVanderbilt University · USCalifornia Pacific Medical Center · USEuropean Institute of Oncology · ITHuntsman Cancer Institute · USJohns Hopkins Medicine · USMoffitt Cancer Center · USNuremberg Hospital · DENYU Langone Health · USPrincess Alexandra Hospital · AUSaint Louis University · USTel Aviv Sourasky Medical Center · ILThe Ohio State University · USThe University of Adelaide · AUUniversity Medical Center Groningen · NLUniversity of California, Los Angeles · US

Funding

SURGICAL ONCOLOGY WITH COMBINATION THERMO-CHEMOTHERAPYP01CA029605 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HOON, DAVE S B · 1985 to 2013
$75.2M
Multicenter Selective Lymphadenectomy Trial (MSLT II) in MelanomaR01CA189163 · NCI · SAINT JOHN'S CANCER INSTITUTE · PI FARIES, MARK B · 2014 to 2018
$8.1M
NCI NIH HHS P01 CA029605NCI NIH HHS R01 CA189163
6 · The paper itself

Abstract

backgroundAlthough a well-established causative relationship exists between smoking and several epithelial cancers, the association of smoking with metastatic progression in melanoma is not well studied. We hypothesized that smokers would be at increased risk for melanoma metastasis as assessed by sentinel lymph node (SLN) biopsy.

methodsData from the first international Multicenter Selective Lymphadenectomy Trial (MSLT-I) and the screening-phase of the second trial (MSLT-II) were analyzed to determine the association of smoking with clinicopathologic variables and SLN metastasis.

resultsCurrent smoking was strongly associated with SLN metastasis (p = 0.004), even after adjusting for other predictors of metastasis. Among 4231 patients (1025 in MSLT-I and 3206 in MSLT-II), current or former smoking was also independently associated with ulceration (p < 0.001 and p < 0.001, respectively). Compared with current smoking, never smoking was independently associated with decreased Breslow thickness in multivariate analysis (p = 0.002) and with a 0.25 mm predicted decrease in thickness.

conclusionThe direct correlation between current smoking and SLN metastasis of primary cutaneous melanoma was independent of its correlation with tumor thickness and ulceration. Smoking cessation should be strongly encouraged among patients with or at risk for melanoma.

Indexed as

Cutaneous Malignant MelanomaFemaleFollow-Up StudiesHumansInternational AgenciesLymphatic MetastasisLymph Node ExcisionMaleMelanomaMiddle AgedPrognosisProspective StudiesSentinel Lymph NodeSentinel Lymph Node BiopsySkin NeoplasmsSmoking

Identifiers

PMID28224364
PMCPMC5553293
OpenAlexW2591137209

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.